FDA Approves First Drug for Treatment of Tardive Dyskinesia
Ingrezza (valbenazine) capsules approved for treatment of adults with tardive dyskinesia
Past Psychiatric Disorders Do Not Raise Risk of Alzheimer’s Disease
But more recent psychiatric symptoms may be part of the disease
Insulin Resistance Predicts Later Cognitive Decline
Higher serum fasting insulin predicts future decline in verbal fluency
Mindfulness Practice Reduces Cortisol Blunting During Chemo
Findings in colorectal cancer patients using mindfulness practice at start of chemo sessions
SGA Prescribing Higher for Veterans With PTSD/Dementia
Prescribing of SGAs to veterans with PTSD down, but consistently increased odds for concurrent dementia
991 Used Oregon’s Physician-Aided Dying Law 1998 to 2015
Most patients were white, older, and college-educated
MACRA Changes Government Approach to Doctor Payment
New approach pays providers based on quality, value, and results delivered, but questions remain
Risk Adjustment, Reinsurance Transfer Offer Financial Benefit
Revenues exceeded claims costs after implementation of these programs
‘SuperAgers’ Have Less Whole-Brain Cortical Volume Loss
Cognitively-average elderly have significantly greater annual percent change compared with SuperAgers
Second Opinion Yields Different Diagnosis for 1 in 5 Patients
In study, 21 percent of cases received final diagnoses that were distinctly different than referral diagnoses
